
==== Front
MoleculesMoleculesmoleculesMolecules1420-3049MDPI 10.3390/molecules15129354molecules-15-09354ArticleSynthesis of New Racemic α,α-Diaminocarboxylic Ester Derivatives Houssine Mabrouk El Abdelrhani Elachqar Anouar Alami 1*Abdelilah El Hallaoui Laboratoire de Chimie Organique Fès, Faculté des Sciences Dhar El Mahraz, Université Sidi Mohamed Ben Abdellah, Morocco*  Author to whom correspondence should be addressed; E-Mail: alamianouar@yahoo.fr; Tel.: 212-5-35-73-3171; Fax: 212-5-35-73-3171.17 11 2010 12 2010 15 12 9354 9363 26 10 2010 19 11 2010 25 11 2010 © 2010 by the authors;2010licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).New racemic methyl or ethyl α-aminoglycinate derivatives were synthesized by N-alkylation of amines (aniline, 4-methylaniline, 2-methylaniline, 2,4-dimethoxyaniline, 2-nitroaniline, 4-chloro-2-fluoroaniline, 2-naphthylamine, benzylamine, N,N-dibenzylamine, and cyclohexylamine) with methyl or ethyl α-azidoglycinate.

amineN-alkylationmethyl α-azidoglycinateα-amino acids
==== Body
1. Introduction
Amino acids are the fundamental building blocks of peptides and proteins and play essential roles in living organisms. Because of the physiological importance of α-amino acids, innumerable studies for their chemistry and synthesis have been published [1,2,3,4]. Along with the elucidation of their distributions, origins and physiological functions, the D-amino acids have been recognized as the candidates for novel physiologically active substances and/or marker molecules of diseases [5,6].

Since the end of last century, the studies of amino acids have changed to focusing on their biochemistry, physiology and medical activities such as apoptosis inducing, platelet aggregation-inhibiting/inducing, antimicrobial, anti-HIV.

The synthesis of amino acids was a very important development [7]. Their applications can be found currently in several domains: biochemistry, enzymology [8,9,10,11], medicine (antibiotics, antiepileptics, antivirals, antiprotozoals, cardiovascular, atherosclerosis, renal failure and diabetes, neuroexciters [12,13,14,15,16,17,18,19,20,21,22,23,24,25,26]), agrochemical industry (herbicides, fungicides, regulation of plant growth), in addition to their important utility as chiral auxiliaries in asymmetric synthesis [27,28]. The development of simple, efficient and highly selective methods for widely used organic compounds from readily available reagents is one of the major challenges in organic synthesis. Among these, C-N bond formation is one of the most important transformations. The reactions of amines have been a topic of immense research interest due to their synthetic utility [29,30,31,32,33] and biological activity [34]. Amines are widely used as intermediates to prepare solvents, fine chemicals, agrochemicals, pharmaceuticals and as polymerization catalysts [35,36,37].

Diaminoacids are important non-protein amino acids, usually components of both natural and synthetic bioactive compounds [38]. In fact, they are currently well recognized as key structural moieties in a variety of biologically active molecules [39,40].

The literature [41,42,43,44,45,46,47,48,49] reports different methods of alkylation, among which phase transfer catalysis, the N-alkylation by microwaves, and the Mitsunobu reaction with organic azides have proved to be efficient key intermediates in organic synthesis for the construction of heterocyclic systems by cycloaddition reactions, while the substitution of the azide group has received much less attention. Continuing our investigations on the use of organic azides [50,51], we report in this paper another part of our investigations concerning the preparation of new α,α-diaminocarboxylic esters derivatives with the aim of providing access to new active biomolecules. 

2. Results and Discussion
Our strategy is based on the N-alkylation of amines with methyl or ethyl α-azidoglycinate 1 (R = CH3) or 1’ (R = C2H5) (Scheme 1). Azide derivatives 1 and 1’ were prepared using Achamlale’s version of the Steglich reaction [52] and [53,54]. The title compounds are stable and can be stored for an unlimited amount of time without any signs of decomposition. Methyl or ethyl α-bromoglycinate also can be used and give satisfactory results; the azide 1 (R = CH3) or 1’ (R = C2H5) are used especially for their stability.

molecules-15-09354-scheme1_Scheme 1Scheme 1 N-alkylation of different amines, with methyl or ethyl α-azidoglycinate 1 (R = CH3) or 1’ (R = C2H5).

As shown in Scheme 1, the N-alkylation reactions of various amine nucleophiles (aniline, 4-methylaniline, 2-methylaniline, 2,4-dimethoxyaniline, 2-nitroaniline, 4-chloro-2-fluoroaniline, 2-naphthylamine, benzylamine, N,N-dibenzylamine, and cyclohexylamine) with N-benzoylated methyl or ethyl α-azido-glycinates 1 (R = CH3) or 1’ (R = C2H5) were performed in dry acetone for 48 h at room temperature in the presence of diisopropylethylamine (DIPEA). The products 2-11 were obtained in good to high chemical yields (62-92%) and were characterized by MS, 1H-NMR and 13C-NMR spectroscopy. The results are summarized in Table 1.

molecules-15-09354-t001_Table 1Table 1 Synthesis of new methyl or ethyl α-aminoglycinates derivatives 2-11.

Entry	Nu-H	Product	m.p. (°C)	Reaction Time (h)	Yield (%)	δHα (ppm)	
1	Aniline	Methyl 2-benzamido-2-(phenylamino)acetate (2)	124-126	48	80	6.22	
2	4-methylaniline (R = Me)	Methyl 2-benzamido-2-(p-tolylamino)acetate (3)	140-142	48	90	6.14	
3	4-methylaniline (R = Et)	Ethyl 2-benzamido-2-(p-tolylamino)acetate (3’)	164-166	48	80	6.11	
4	2-methylaniline	Methyl 2-benzamido-2-(o-tolylamino)acetate (4)	128-130	48	90	6.22	
5	2,4-dimethoxy-aniline	Methyl 2-benzamido-2-(2,4-dimethoxyphenylamino)acetate (5)	170-172	48	86.5	6.15	
6	4-chloro-2-fluoro-aniline	Methyl 2-benzamido-2-(4-chloro-2-fluorophenylamino)acetate (6)	152-154	48	90	6.20	
7	2-nitroaniline	Ethyl 2-benzamido-2-(2-nitrophenylamino)acetate (7)	173-174	48	86	6.82	
8	2-naphthylamine	Ethyl 2-benzamido-2-(2-naphthylamino)acetate (8)	210-212	48	62	6.25	
9	Benzylamine	Methyl 2-benzamido-2-(benzylamino)acetate (9)	104-106	48	76	5.56	
10	N,N-dibenzyl-amine	Methyl 2-benzamido-2-(N,N-dibenzylamino)acetate (10)	130-132	48	84	5.58	
11	2-amino-cyclohexane	Methyl 2-benzamido-2-(cyclohexylamino)acetate (11)	182-184	48	92	5.72	
Comparing these results with only the work done by our team [41,50,51], we see that we obtained almost identical results. The molecule 2 used for previous work as a reference model. In continuation of that work, we studied herein the influence of donors and withdrawing groups on the the aromatic ring of the aniline moiety on the NMR chemical shifts of these systems. In molecule 2 used as a reference, the proton on the carbon α to the carboxylate group appears as a doublet at 6.22 ppm. When the aromatic ring bears a donor group in positions 2 or 4 (entries 2, 3 and 4), the chemical shift of the α-proton does not undergo any major changes (δCH = 6.14-6.20 ppm).

It should be noted that in the 1H-NMR spectrum of pure product 6 the α-proton at 6.20 ppm appears as a multiplet. The chemical shift is practically the same as that of the α-proton in the reference molecule 2, and the splitting is probably due to the opposite effects (+ M) and (− I) of the two halogen atoms (fluorine in position 2 and chlorine in position 4) on the aromatic ring.

In molecule 7, the α-proton multiplet underwent a deshielding of 6.22 to 6.82 ppm due to the presence of an electron withdrawing group [with inductive and mesomeric effects (− I, − M)] at the ortho position of the aromatic aniline system. In the case of benzylamine, dibenzylamine and cyclohexylamine as N-alkylation reagents, the chemical shift of the α-hydrogen undergoes a shielding of about 0.60 ppm (6.22 to 5.62 ppm) compared to molecule 2 used as a reference model (products 9, 10 and 11). This can be justified by the electrondonor effect (+ I) of the benzyl and cyclohexyl groups.

In conclusion, this method provides a convenient method and easy procedure for the preparation of new methyl or ethyl α-aminoglycinate derivatives starting from the appropriate azide derivatives 1 (R = CH3) or 1’ (R = C2H5). The N-alkylation of various amines (aniline, 4-methylaniline, 2-methylaniline, 2,4-dimethoxyaniline, 2-nitroaniline, 4-chloro-2-fluoroaniline, 2-naphthylamine, benzylamine, N,N-dibenzylamine, and cyclohexylamine) with azide occurred under very mild conditions and led after a reaction time of about 48 h to the desired products in very satisfactory yields (Table 1).The nucleophilic nature of the reagents has an immediate influence on the α-hydrogen acidity and its possible effect the reactivity of the α,α-diamino acids.

3. Experimental
3.1. General
Melting points were determined with an Electrothermal melting point apparatus and are uncorrected. NMR spectra (1H, 13C) were recorded on a Bruker AM 300 (operating at 300.13 MHz for 1H, at 75.47 MHz for 13C) spectrometer (Centre Universitaire Régional d’Interface, Fès). NMR data are listed in ppm and are reported relative to tetramethylsilane (1H, 13C); residual solvent peaks being used as internal standard. All reactions were followed by TLC. TLC analyses were carried out on 0.25 mm thick precoated silica gel plates (Merck Fertigplatten Kieselgel 60F254) and spots were visualised under UV light or by exposure to vaporised iodine. Mass spectra were recorded by electrospray on a micromass ESl Platform II (Université Montpellier II, France) and on a PolarisQ Ion Trap GC/MSn Mass Spectrometer (Centre Universitaire Régional d’Interface, Fès). Methyl α-azidoglycinate 1 (R = CH3) or 1’ (R = C2H5) was prepared using Achamlale’s method [53,54].

3.2. Typical Procedure for N-Alkylation
To a stirred solution of amine (2.86 mmol) and diisopropylethylamine (3.12 mmol) in dry acetone (10 mL), α-azidoglycinate (2.6 mmol) was added. The mixture was stirred at room temperature and the reaction was followed by TLC (Kiesegel Merck 60F524). The solvent was evaporated under reduced pressure. The residue was quenched with saturated aqueous solution of ammonium chloride (20 mL) and extracted with dichloromethane(20 mL × 3). The organic phase was dried in sodium sulfate (Na2SO4) and the solvent was removed under reduced pressure. The product was purified by column chromatography on silica gel using ether/hexane as eluant to afford pure N-alkylated product. 

Methyl 2-benzamido-2-(phenylamino)acetate (2): Yield 80%; Solid, m.p. 124-126 °C (ether/hexane); Rf = 0.75 (ether); 1H-NMR (CDCl3, ppm): δ = 7.80 (m, 2H, Harom), 7.56-7.49 (m, 4H, Harom), 7.15-7.09 (m, 2H, NHamid + Harom), 6.79-6.68 (m, 3H, Harom), 6.22 (d, 1H, Hα, 8 Hz), 4.91 (br s, 1H, NH), 3.87 (s, 3H, OCH3); 13C-NMR (CDCl3, ppm): δ = 170.0, 166.7 (CO), 146.2, 133.7, 132.2 (2C), 129.4, 128.8 (2C), 127.9 (2C), 118.0, 113.5 (2C) (C6H5 aromatic carbons), 60.9(-CH-), 53.0 (CH3O); MS (electrospray) m/z: 285.2 (M + 1, 9%), 164 (100%), 104 (21%); (Formula: C16H16N2O3).

Methyl 2-benzamido-2-(p-tolylamino)acetate (3): Yield 90%; Solid, m.p. 140-142 °C (ether/hexane); Rf = 0.67 (ether); 1H-NMR (CDCl3, ppm): δ = 7.76 (m, 2H, Harom), 7.52-7.40 (m, 3H, Harom), 7.02 (m, 2H, NHamid + Harom), 6.77-6.67 (m, 3H, Harom), 6.14 (d, 1H, Hα, 7.8 Hz), 4.90 (br s, 1H, NH), 3.86 (s, 3H, OCH3), 2.24 (s, 3H, CH3); 13C-NMR (CDCl3, ppm): δ = 170.5, 167.2 (CO), 141.6, 133.2, 132.1, 130.0 (2C), 129.0, 128.7 (2C), 127.2 (2C), 114.2 (2C) (C6H5 aromatic carbons), 61.1 (-CH-), 53.4 (OCH3), 20.5 (CH3); EIMS m/z: 298 (M+., 12%), 239 (88%), 122 (38%), 105 (100%), 77 (59%); (Formula: C17H18N2O3).

Ethyl 2-benzamido-2-(p-tolylamino)acetate (3’): Yield 80%; Solid, m.p. 164-166 °C (ether/hexane);Rf = 0.72 (ether); 1H-NMR (CDCl3, ppm): δ = 7.75 (m, 2H, NHamid + Harom), 7.52-7.40 (m, 3H, Harom), 7.02 (m, 2H, NHamid + Harom), 6.82-6.69 (m, 3H, Harom), 6.11 (d, 1H, Hα, 7.9Hz), 4.90 (br s, 1H, NH), 4.32 (q, 2H, OCH2, 7.05Hz), 2.25 (s, 3H, CH3), 1.33 (t, 3H, CH3, 7.05Hz); 13C-NMR (CDCl3, ppm):δ = 170.0, 167.3 (CO), 141.7, 133.4, 132.0, 130.0 (2C), 128.9, 128.6 (2C), 127.1 (2C), 114.3 (2C) (C6H5 aromatic carbons), 62.6 (-CH-), 61.3 (CH3CH2O), 20.5 (CH3), 14.9 (CH3CH2O); MS (electrospray) m/z: 313.2 (M + 1, 11.81 %); 239.1 (88.58%), 192.1 (11.82%), 136.1(37.80%), 118.0 (59.06%), 105.0 (100%); (Formula: C18H20N2O3).

Methyl 2-benzamido-2-(o-tolylamino)acetate (4): Yield 90%; Solid, m.p. 128-130 °C (ether/hexane); Rf = 0.62 (ether);1H-NMR (CDCl3, ppm): δ = 7.85 (m, 2H, Harom), 7.56-7.41 (m, 3H, Harom), 7.15-7.09 (m, 2H, NHamid + Harom), 6.79-6.68 (m, 3H, Harom), 6.22 (d, 1H, Hα, 8 Hz), 5.05 (br s, 1H, NH), 3.88 (s, 3H, OCH3), 2.24 (s, 3H, CH3); 13C-NMR (CDCl3, ppm): δ = 170.6, 167.2 (CO), 142.2, 133.2, 132.2, 130.6, 128.7 (2C), 127.4, 127.2 (2C), 123.1, 119.2, 111.3 (C6H5 aromatic carbons), 60.7 (-CH-), 53.4 (OCH3), 17.5 (CH3); EIMS m/z: 298 (M+.,14%), 239 (87%), 122 (64%), 105 (100%), 77 (69%); (Formula: C17H18N2O3).

Methyl 2-benzamido-2-(2,4-dimethoxyphenylamino)acetate (5): Yield 86.5%; Solid, m.p. 170-172 °C (ether/hexane); Rf = 0.69 (ether);1H-NMR (CDCl3, ppm): δ = 7.78 (m, 2H, Harom), 7.55-7.30 (m, 3H, Harom), 6.90-6.38 (m, 4H, NHamid + Harom), 6.15 (d, 1H, Hα, 7.8Hz), 5.10 (br s,1H, NH), 3.85 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 3.74 (s, 3H, OCH3); 13C-NMR (CDCl3, ppm): δ = 170.5, 167.2 (CO), 153.7, 148.7, 133.4, 132.0, 128.6 (2C), 127.8, 127.4 (2C), 112.9, 103.9, 99.3 (C6H5 aromatic carbons), 61.3 (-CH-), 55.6, 55.5, 53.2 (OCH3); MS (electrospray) m/z: 345.2 (M + 1, 17.45%), 224.2 (79.19%), 192.2 (3.36%), 164.3 (11.41%); (Formula: C18H20N2O5).

Methyl 2-benzamido-2-(4-chloro-2-fluorophenylamino)acetate (6): Yield 90%; Solid, m.p. 152-154 °C (ether/hexane); Rf = 0.87 (ether);1H-NMR (CDCl3, ppm): δ = 7.78 (m, 2H, Harom), 7.62-7.41 (m, 3H, Harom), 7.05-6.85 (m, 4H, NHamid + Harom), 6.20 (m, 1H, Hα), 5.15 (br s, 1H, NH), 3.85 (s, 3H, OCH3); 13C-NMR (CDCl3, ppm): δ = 169.8, 167.3 (CO), 152.6, 132.9, 132.3, 131.5, 128.8 (2C), 127.3 (2C), 124.9, 123.7, 115.7, 114.6 (C6H5 aromatic carbons), 60.0 (-CH-), 53.5 (OCH3); MS (electrospray) m/z: 361.1 (6.41%), 359.1 (16.99%), 337.1 (M + 1, 7.05%), 218.2 (32.05%), 216.2 (100%), 122.3 (58.33%); (Formula: C16H14ClFN2O3).

Ethyl 2-benzamido-2-(2-nitrophenylamino)acetate (7): Yield 86%; Solid, m.p. 173-174 °C (ether/hexane); Rf = 0.83 (ether);1H-NMR (CDCl3, ppm): δ = 8.85 (br s, 1H, NHamid), 8.25-6.92 (5m, 9H, Harom), 6.82 (m, 1H, Hα), 6.45 (br s, 1H, NH), 4.35 (q, 2H, OCH2, 7.1Hz), 1.35 (t, 3H, CH3, 7.1Hz); 13C-NMR (CDCl3, ppm): δ = 168.5, 167.1 (CO), 142.0, 136.6, 133.6, 132.9, 132.4, 128.8 (2C), 127.2 (2C), 126.8, 117.8, 115.1 (C6H5 aromatic carbons), 63.1 (-CH-); 59.3 (CH3CH2O); 14.0 (CH3CH2O); MS (electrospray) m/z: 366.2 (26.75%), 344.1 (M + 1, 17.52%), 223.2 (47.77%), 206.2 (57.96%), 105.3 (100%); (Formula: C17H17N3O5).

Ethyl 2-benzamido-2-(naphthalen-2-ylamino)acetate (8): Yield 62%; Solid, m.p. 210-212 °C (ether/hexane); Rf = 0.67 (ether);1H-NMR (CDCl3, ppm): δ = 7.85 (m, 2H, Harom), 7.71-7.64 (m, 3H, Harom), 7.51-7.25 (m, 6H, Harom), 7.07 (m, 2H, NHamid + Harom), 6.87 (d, 1H, NH, 8.0Hz), 6.25 (d, 1H, Hα, 8.0Hz), 4.35 (q, 2H, OCH2, 7.1Hz), 1.34 (t, 3H, CH3, 7.1Hz); MS (electrospray) m/z: 697.3 (2M+1, 4.17%), 349.2 (M + 1, 8.01%), 154.3 (3.21%), 228.1 (100%); (Formula: C21H20N2O3).

Methyl 2-benzamido-2-(benzylamino)acetate (9): Yield 76%; Solid, m.p. 104-106 °C (ether/hexane); 6.97 (m, 1H, NH), 5.56 (d, 1H, Hα, 7.5Hz), 3.87 (d, 2H, CH2, 9.8 Hz), 3.79 (s, 3H, OCH3); 13C-NMR (CDCl3, ppm): δ = 170.8, 167.4 (CO), 139.2, 133.4, 132.1, 128.7 (2C), 128.5 (2C), 128.3 (2C), 127.3, 127.1 (2C) (C6H5 aromatic carbons), 65.0 (-CH-), 53.0 (OCH3), 49.2 (CH2); EIMS m/z: 298.8 (M+., 100%), 239 (25%), 178 (67%), 105 (31%), 91 (24%), 77 (10%); (Formula: C17H18N2O3).

Methyl 2-benzamido-2-(N,N-dibenzylamino)acetate (10): Yield 84%; Solid, m.p. 130-132 °C (ether/ hexane); Rf = 0.82 (ether); 1H-NMR (CDCl3, ppm): δ = 7.87 (d, 1H, NHamid, 7.3 Hz), 7.50 (m, 15H, Harom), 5.58 (d, 1H, Hα, 7.3 Hz), 3.95 (br s, 4H, NCH2), 3.85 (s, 3H, OCH3); 13C-NMR (CDCl3, ppm): δ = 170.4, 167.9 (CO), 139.6 (2C), 133.2, 132.2, 129.0 (4C), 128.8 (4C), 128.6 (2C), 128.3 (2C), 127.0 (2C) (C6H5 aromatic carbons), 66.5 (-CH-); 54.1 (2C) (CH2), 52.7 (OCH3); EIMS m/z: 389.9 (M + 1, 25.20%), 388.9 (M+., 100%), 329.3 (68.50%), 268.3 (93.70%), 196.2 (41.73%), 105.2 (22.05%), 77.3 (55.91%); (Formula: C24H24N2O3).

Methyl 2-benzamido-2-(cyclohexylamino)acetate (11): Yield 92%; Solid, m.p. 182-184 °C (ether/ hexane); Rf = 0.6 (ether); 1H-NMR (CDCl3, ppm): δ = 8.02-7.99 (m, 2H, NHamid + Harom), 7.56-7.46 (m, 4H, Harom), 5.72 (d, 1H, Hα, 6.18Hz), 3.87 (s, 3H, OCH3), 2.83-0.87 (m, 12H, Hcyc + NH); 13C-NMR (CDCl3, ppm): δ = 170.9, 167.4 (CO), 133.4, 132.0, 128.7 (2C), 127.4 (2C) (C6H5 aromatic carbons), 63.0 (-CH-), 56.0 (OCH3), 52.7 (-CHCH2-), 32.5 (2C), 26.3 (2C), 25.2 (CH2); EIMS m/z: 289.1 (M+., 14.29%), 231.2 (100%), 170.2 (47.62%), 105.4 (88.10%), 77.4 (28.17%); (Formula: C16H22N2O3).

Acknowledgements
We thank the CNR for financial support of this work (PROTARS D13/03, Morocco).
==== Refs
References and Notes
1. Duthaler R.O.   Recent developments in the stereoselective synthesis of alpha-amino acids Tetrahedron 1994 50 1539 1650 10.1016/S0040-4020(01)80840-1 
2. Beller M.  Eckert M.   Amidocarbonylation-an efficient route to amino acid derivatives Angew. Chem. 2000 39 1011 1027 
3. Palacios F.  Alonso C.  de los Santos J.M.   Synthesis of β -aminophosphonates and phosphinates Chem. Rev. 2005 105 899 932 10.1021/cr040672y 15755080 
4. Jin L.  Song B.  Zhang G.  Xu R.  Zhang S.  Gao X.  Hu D.  Yang S.   Synthesis, X-ray crystallographic analysis, and antitumor activity of N -(benzothiazole-2-yl)-1-(fluorophenyl)-O ,O -dialkyl-α-aminophosphonates Bioorg. Med. Chem. Lett. 2006 16 1537 1543 10.1016/j.bmcl.2005.12.041 16406612 
5. Pollegioni L.  Piubelli L.  Sacchi S.  Pilone M.S.  Molla G.   Physiological functions of D-amino acid oxidases: from yeast to humans Cell. Mol. Life Sci. 2007 64 1373 1394 10.1007/s00018-007-6558-4 17396222 
6. Sacchi S.  Bernasconi M.  Martineau M.  Mothet J.P.  Ruzzene M.  Pilone M.S.  Pollegioni L.  Molla G.   pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility J. Biol. Chem. 2008 283 22244 22256 18544534 
7. Haemers A.  Mishra L.  Van Assche I.  Bolleart W.   Asymmetric synthesis of amino acids by enantio- and diastereodifferentiating reactions Die Pharmazie 1989 44 97 109 
8. Mikolajczyk M.   Acyclic and cyclic aminophosphonic acids: asymmetric syntheses mediated by chiral sulfinyl auxiliary J. Organomet. Chem. 2005 690 2488 2496 10.1016/j.jorganchem.2004.10.045 
9. Meyer F.  Laaziri A.  Papini A.M.  Uziel J.  Juge S.   A novel phosphorus-carbon bond formation by ring opening with diethyl phosphite of oxazolines derived from serine Tetrahedron 2004 60 3593 3597 10.1016/j.tet.2004.03.001 
10. Rodrigues R.S.  da Silva J.F.  Boldrini-FranÇa J.  Fonseca F.P.P.  Otaviano A.R.  Henrique-Silva F.  Magro A.J.  Braz A.S.K.  dos Santos J.I.  Homsi-Brandeburgo M.I.  Fontes M.R.M.  Fuly A.L.  Soares A.M.  Rodrigues V.M.   Structural and functional properties of Bp-LAAO, a new L-amino acid oxidase isolated from Bothrops pauloensis snake venom Biochimie 2009 91 490 501 10.1016/j.biochi.2008.12.004 19135502 
11. Samel M.  Tõnismägi K.  Rönnholm G.  Vija H.  Siigur J.  Kalkkinen N.  Siigur E.   L-Amino acid oxidase from Naja naja oxiana venom Comp. Biochem. Physiol. 2008 B 149 572 580 
12. Leite A.L.  Lima R.S.  Moreira D.R.M.  Cardoso M.V.  Brito A.C.G.  Santos L.M.F.  Hernandes M.Z.  Kiperstok A.C.  Lima R.S.  Soares M.B.P.   Synthesis, docking, and in vitro  activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against Trypanosoma cruzi Bioorg. Med. Chem. 2006 14 3749 3757 10.1016/j.bmc.2006.01.034 16458521 
13. Moreira D.R.  Leite A.C.L.  Ferreira P.M.  da Costa P.M.  Costa Lotufo L.V.  de Moraes M.O.  Brondani D.J.  Pessoa Cdo.O.   Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system Eur. J. Med. Chem. 2007 42 351 357 10.1016/j.ejmech.2006.10.007 17175071 
14. Ciscotto P.  Machado de Avila R.A.  Coelho E.A.F.  Oliveira J.  Diniz C.G.  Farǐas L.M.  de Carvalho M.A.R.  Maria W.S.  Sanchez E.F.  Borges A.  Chavez-Olőrtegui C.    Antigenic, microbicidal and antiparasitic properties of an L-amino acid oxidase isolated from Bothrops jararaca snake venom Toxicon 2009 53 330 341 10.1016/j.toxicon.2008.12.004 19101583 
15. Becker S.S.  Russell P.T.  Duncavage J.A.  Creech C.B.   Current issues in the management of sinonasal methicillin-resistant Staphylococcus aureus. Curr. Opin. Otolaryngol Head Neck Surg. 2009 17 2 5 10.1097/MOO.0b013e32831b9c97 
16. Li R.  Zhu S.W.  Wu J.B.  Wang W.Y.  Lu Q.M.  Clemetson K.J.   L-Amino acid oxidase from Naja atra venom activates and binds to human platelets. Acta Biochim  Biophys. Sin. (Shanghai) 2008 40 19 26 10.1111/j.1745-7270.2008.00372.x 
17. Alves R.M.  Antonucci G.A.  Paiva H.H.  Cintra A.C.O.  Franco J.J.  Mendonça-Franqueiro E.P.  Dorta D.J.  Giglio J.R.  Rosa J.C.  Fuly A.L.  Dias-Baruffi M.  Soares A.M.  Sampaio S.V.   Evidence of aspase mediated apoptosis induced by L-amino acid oxidase isolated from Bothrops atrox snake venom Comp. Biochem. Physiol. 2008 A 151 542 550 
18. Trouet A.  Passioukov A.  Van Derpoorten K.  Fernandez AM.  Baurain R.  Abarca-Quinones J.  Lobl TJ.  Oliyai C.  Shochat D.  Dubois V.   Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro  and in vivo  studies Cancer Res. 2001 61 2843 2846 11306455 
19. Wei X.L.  Wei J.F.  Li T.  Qiao L.Y.  Liu Y.L.  Huang T.  He S.H.   Purification, characterization and potent lung lesion activity of an L-amino acid oxidase from Agkistrodon blomhoffii ussurensis snake venom Toxicon 2007 50 1126 1139 10.1016/j.toxicon.2007.07.022 17854853 
20. Sant’Ana C.D.  Menaldo D.L.  Costa T.R.  Godoy H.  Muller V.D.  Aquino V.H.  Albuquerque S.  Sampaio S.V.  Monteiro M.C.  Stábeli R.G.  Soares A.M.   Antiviral and antiparasite properties of an L-amino acid oxidase from the snake Bothrops jararaca: cloning and identification of a complete cDNA sequence Biochem. Pharmacol. 2008 76 279 288 18555977 
21. Moore J.D.  Sprott K.T.  Hanson P.R.   Conformationally constrained α-Boc-aminophosphonates via transition Metal-Catalyzed/Curtius rearrangement strategies J. Org. Chem. 2002 67 8123 8129 10.1021/jo0262208 12423141 
22. Stábeli R.G.  Sant’Ana C.D.  Ribeiro P.H.  Costa T.R.  Ticli F.K.  Pires M.G.  Nomizob A.  Albuquerque S.  Malta-Neto N.R.  Marins M.  Sampaio S.V.  Soares A.M.   Cytotoxic L-amino acid oxidase from Bothrops moojeni: biochemical and functional characterization Int. J. Biol. Macromol. 2007 41 132 140 10.1016/j.ijbiomac.2007.01.006 17320169 
23. Leite A.C.L.  Silva K.P.  Souza I.A.  Janete M.A.  Dalci J.   Synthesis, antitumour and antimicrobial activities of new peptidyl derivativescontaining the 1,3-benzodioxole system Eur. J. Med. Chem. 2004 39 1059 1065 10.1016/j.ejmech.2004.09.007 15571867 
24. Samel M.  Vija H.  Rönnholm G.  Siigur J.  Kalkkinen N.  Siigur E.   Isolation and characterization of an apoptotic and platelet aggregation inhibiting L-amino acid oxidase from Vipera berus berus (common viper) venom Biochim. Biophys. Acta 2006 1764 707 714 10.1016/j.bbapap.2006.01.021 16574513 
25. Tőnismägi K.  Samel M.  Trummal K.  Rőnnholm G.  Siigur J.  Kalkkinen N.  Siigur E.   L-Amino acid oxidase from Vipera lebetina venom: isolation, characterization, effects on platelets and bacteria Toxicon 2006 48 227 237 10.1016/j.toxicon.2006.05.004 16828829 
26. Ande S.R.  Fussi H.  Knauer H.  Murkovic M.  Ghisla S.  Fröhlich K.U.  Macheroux P.   Induction of apoptosis in yeast by L-amino acid oxidase from the Malayan pit viper Calloselasma rhodostoma Yeast 2008 25 349 357 10.1002/yea.1592 18437704 
27. Reider P.J.  Eichen Conn R.S.  Davis P.  Grenda V.J.  Zambito A.J.  Grabowski E.J.J.   Synthesis of (R )-serine-2-d and its conversion to the broad sprectrum antibiotic fludalanine J. Org. Chem. 1987 52 3326 3334 10.1021/jo00391a029 
28. Saravanan P.  Corey E.J.   A short, stereocontrolled, and practical synthesis of alpha-methylomuralide, a potent inhibitor of proteasome function J. Org. Chem. 2003 68 2760 2764 10.1021/jo0268916 12662049 
29. Wang M.  Gould S.J.   Biosynthesis of capreomycin. 2. Incorporation of L-serine, L-alanine, and L-2,3-diaminopropionic acid J. Org. Chem. 1993 58 5176 5180 10.1021/jo00071a029 
30. Shen H.  Xie Z.   Titanacarborane mediated C-N bond forming/breaking reactions J. Organomet. Chem. 2009 694 1652 1657 10.1016/j.jorganchem.2008.11.010 
31. Mohammad N.S.R.  Ali K.N.  Somayeh B.  Mohammad A.F.  Abdolkarim Z.  Abolfath P.    One-pot synthesis of N -alkyl purine and pyrimidine derivatives from alcohols using TsIm: a rapid entry into carboacyclic nucleoside synthesis Tetrahedron 2008 64 1778e 1785e 10.1016/j.tet.2007.11.101 
32. Manoj N.  Vijay V.B.   Selective N -alkylation of aniline with methanol over a heteropolyacid on montmorillonite K10 Appl. Clay Sci. 2009 44 255 258 10.1016/j.clay.2009.02.011 
33. Martínez-Asencio A.  Ramon D.J.  Miguel Y.   N -Alkylation of poor nucleophilic amine and sulfonamide derivatives with alcohols by a hydrogen autotransfer process catalyzed by copper (II) acetate Tetrahedron Lett. 2010 51 325 327 10.1016/j.tetlet.2009.11.009 
34. Shmidt M.S.  Reverdito A.M.  Kremenchuzky L.  Perillo I.A.  Blanco M.M.   Simple and efficient microwave assisted N -alkylation of Isatin Molecules 2008 13 831 840 10.3390/molecules13040831 18463585 
35. Kiuchi F.  Nishizawa S.  Kawanishi H.  Kinoshita S.  Ohsima H.  Uchitani A.  Sekino N.  Ishida Kondo M.K.  Tsuda Y.   Studies on crude drugs effective on visceral larva migrans. XVI. Nematocidal activity of long alkyl chain amides, amines, and their derivatives on dog roundworm larvae Chem. Pharma. Bull. Jpn. 1992 40 3234 3244 10.1248/cpb.40.3234 
36. Seayad A.M.A.  Klein H.  Jackstell R.  Gross T.  Beller M.   Internal olefins to linear amines Science 2002 297 1676 1678 10.1126/science.1074801 12215640 
37. Kim J.W.  Yamaguchi K.  Mizuno N.   Heterogeneously catalyzed selective N -alkylation of aromatic and heteroaromatic amines with alcohols by a supported ruthenium hydroxide J. Catal. 2009 263 205 208 10.1016/j.jcat.2009.01.020 
38. Reddy C.R.  Jithender E.   Acid-catalyzed N -alkylation of tosylhydrazones using benzylic alcohols Tetrahedron Lett. 2009 50 5633 5635 10.1016/j.tetlet.2009.07.093 
39. Ojima I.  Delaloge F.   Asymmetric synthesis of building-blocks for peptides and peptidomimetics by means of the β-lactam synthon method Chem. Soc. Rev. 1997 26 377 386 10.1039/cs9972600377 
40. Rane D.F.  Girijavallabhan V.M.  Ganguly A.K.  Pike R.E.  Saksena A.K.  McPhail A.T.   Total synthesis and absolute stereochemistry of the antifungal dipeptide Sch 37137 and its 2S,3S-isomer Tetrahedron Lett. 1993 34 3201 3204 
41. Bentama A.  El Hadrami E.M.  El Hallaoui A.  Elachqar A.    Synthesis of new α-heterocyclic α-aminoesters Amino Acids 2003 24 423 426 10.1007/s00726-002-0323-7 12768505 
42. Maheswaran H.  Gopi K.G.  Leon P.K.  Srinivas V.  Chaitanya G.K.  Bhanuprakash K.   Bis(μ-iodo)bis((−)-sparteine)dicopper(I): versatile catalyst for direct N -arylation of diverse nitrogen heterocycles with haloarenes Tetrahedron 2008 64 2471 2479 10.1016/j.tet.2007.12.050 
43. Spreitzer H.  Puschmann C.   Regioselective Alkylation of an oxonaphthalene-annelated pyrrol system Molbank 2009 3 M619 10.3390/M619 
44. Won K.J.  Yamaguchi K.  Mizuno N.   Heterogeneously catalyzed selective N -alkylation of aromatic and heteroaromatic amines with alcohols by a supported ruthenium hydroxide J. Catal. 2009 263 205 208 10.1016/j.jcat.2009.01.020 
45. Raji R.C.  Jithender E.   Acid-catalyzed N -alkylation of tosylhydrazones using benzylic alcohols Tetrahedron Lett. 2009 50 5633 5635 10.1016/j.tetlet.2009.07.093 
46. Fletcher S.   Regioselective alkylation of the exocyclic nitrogen of adenine and adenosine by the Mitsunobu reaction Tetrahedron Lett. 2010 51 2948 2950 10.1016/j.tetlet.2010.03.103 
47. Martínez-Asensio A.  Ramón D. J.  Yus M.   N -Alkylation of poor nucleophilic amine and sulfonamide derivatives with alcohols by a hydrogen autotransfer process catalyzed by copper(II) acetate Tetrahedron Lett. 2010 51 325 327 10.1016/j.tetlet.2009.11.009 
48. Zarubaev V.V.  Golod E.L.  Anfimov P.M.  Shtro A.A.  Saraev V.V.  Gavrilov A.S.  Logvinov A.V.  Kiselev O.I.   Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus Bioorg. Med. Chem. 2010 18 839 848 20006516 
49. Shibinskaya M.O.  Lyakhov S.A.  Mazepa A.V.  Andronati S.A.  Turov A.V.  Zholobak N.M.  Spivak N.Y.   Synthesis, cytotoxicity, antiviral activity and interferon inducing ability of 6-(2-aminoethyl)-6H-indolo[2,3-b]quinoxalines Eur. J. Med. Chem. 2010 45 1237 1243 10.1016/j.ejmech.2009.12.014 20056519 
50. Boukallaba K.  Elachqar A.  El Hallaoui A.  Alami A.  El Hajji S.  Labriti B.  Martinez J.  Rolland V.   Synthesis of new α-heterocyclic α-aminophosphonates Phosphor. Sulfur Silicon 2006 181 819 823 10.1080/10426500500272046 
51. Boukallaba K.  Elachqar A.  El Hallaoui A.  Alami A.  El Hajji S.  Labriti B.  Lachkar M.  Bali B.  Bolte M.  Martinez J.  Rolland V.   Synthesis of α-heterocyclic α-Aminophosphonates, Part II: morpholine, piperidine, pyrrolidine, tetrahydrofurylmethylamine, N -benzyl-N -methylamine, and aniline derivatives Phosphor. Sulfur Silicon 2007 182 1045 1052 10.1080/10426500601093739 
52. Steglich W.  Kober R.   Untersuchungen zur Reaktion von Acylaminobrommalonestern und Acylaminobromessigestern mit Trialkylphosphiten-eine einfache Synthese von 2-Amino-2-(diethoxyphosphoryl)Essigsäure Ethylester Liebigs Ann Chem. 1983 4 599 609 
53. Achamlale S.  Elachqar A.  El Hallaoui A.  El Hajji S.  Roumestant M.L.  Viallefont P.H.   Synthesis of α-triazolyl α-aminoacid derivatives Amino Acids 1997 12 257 263 10.1007/BF01373006 
54. Achamlale S.  Elachqar A.  El Hallaoui A.  El Hajji S.  Alami A.  Roumestant M.L.  Viallefont P.H.   Synthesis of biheterocyclic α-aminoacid Amino Acids 1999 17 149 163 10.1007/BF01361878 10524273

